C. difficile: a menace in hospitals and homes alike.
Oriola
Shannon
S
Sharp Metropolitan Medical Campus, San Diego, CA, USA.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002170:Canada / Q000453:epidemiology; D016360:Clostridioides difficile / Q000145:classification / Q000472:pathogenicity; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D004761:Enterocolitis, Pseudomembranous / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D004866:Equipment Contamination / Q000517:prevention & control; D006801:Humans; D017053:Infection Control / Q000379:methods*; D024802:Nurse's Role; D009730:Nursing Assessment; D011159:Population Surveillance; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents